Influence of gender difference on prognosis in patients with diabetes complicated by heart failureFANG Zhen, JI Jun, WANG Daxin, SHI Chunyu, GE Zhichen, ZHANG Jing1281-1286
Introduction to the application of GEPIA database in disease gene expression analysisCHEN Xinhuan, GENG Hui, HAO Hua, JIANG Hong, MA Mao1287-1292
Relationship between cardiometabolic index and myocardial infarction section studyCHEN Peng, BAI Jing, LI Huaqing, ZHANG Bin, YANG Lilan1293-1299
Role and mechanism of nucleobindin 1 in inflammatory response in rats after myocardial infarctionLIU Liyuan, LI Bin, WU Xingliang, HUANG Yanxin, YI Xin1300-1306
Alleviation of cardiomyocyte senescence by silent information regulator 6 through up-regulating FOXM1/Wnt/β-catenin signaling pathwayMA Yongxiang, SHEN Jing, LU Zhenhua, ZHANG Jing, NIU Lijian, HUANG Wenjun1307-1312
Effect of noninvasive glucose monitoring system on blood sugar control in patients with coronary heart disease complicated by type 2 diabetes mellitusSHI Chunchun, ZHAO Guorong, LI Zhongxuan, TIAN Xinli, ZHANG Yanlin, HAN Baoshi, SHI Yujie1313-1316
Correlation among miR-499a-5p,Toll-like receptor 2 and major adverse cardiovascular events in patients with coronary heart diseasePAN Linyan, XU Xianjin, WANG Niandong1317-1321
Correlation among neutrophil gelatinase-associated lipocalin,adiponectin,soluble suppression of tumorigenicity 2,C-type natriuretic peptide and left ventricular hypertrophy in patients with essential hypertensionMA Hong'en, WANG Xin, JI Zhaohong, WEI Wenyang, ZHOU Na1322-1327
Influence of evolocumab on lipid metabolism and major adverse cardiovascular events in patients with acute coronary syndrome treated with PCIQIU Yan, GUO Liangmin, YUAN Longhui, CAO Shuxian, YANG Mengmeng, WANG Yinli1328-1332
Influence of evolocumab on long-term prognosis in patients with non-ST-segment elevation acute coronary syndromesLIU Yang, WANG Zihan, CHEN Qi, JI Jinrui, XUE Bin, WEI Xiaoyun, LIU Hengliang1333-1338